118 related articles for article (PubMed ID: 37333140)
81. Analysis of IGFBP7 expression characteristics in pan-cancer and its clinical relevance to stomach adenocarcinoma.
Xu HW; Wang MQ; Zhu SL
Transl Cancer Res; 2023 Oct; 12(10):2596-2612. PubMed ID: 37969374
[TBL] [Abstract][Full Text] [Related]
82. IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
Akiel M; Guo C; Li X; Rajasekaran D; Mendoza RG; Robertson CL; Jariwala N; Yuan F; Subler MA; Windle J; Garcia DK; Lai Z; Chen HH; Chen Y; Giashuddin S; Fisher PB; Wang XY; Sarkar D
Cancer Res; 2017 Aug; 77(15):4014-4025. PubMed ID: 28619711
[TBL] [Abstract][Full Text] [Related]
83. Psoriasis and Pro-angiogenetic Factor CD93: Gene Expression and Association with Gene Polymorphism Suggests a Role in Disease Pathogenesis.
Duvetorp A; Slind Olsen R; Skarstedt M; Söderman J; Seifert O
Acta Derm Venereol; 2017 Aug; 97(8):916-921. PubMed ID: 28421233
[TBL] [Abstract][Full Text] [Related]
84. Soluble CD93 lectin-like domain sequesters HMGB1 to ameliorate inflammatory diseases.
Huang SE; Kuo CH; Shiao SY; Shen CR; Lee FT; Chang BI; Hsu JH; Wu HL; Yeh JL; Lai CH
Theranostics; 2023; 13(12):4059-4078. PubMed ID: 37554277
[No Abstract] [Full Text] [Related]
85. Metoclopramide treatment blocks CD93-signaling-mediated self-renewal of chronic myeloid leukemia stem cells.
Riether C; Radpour R; Kallen NM; Bürgin DT; Bachmann C; Schürch CM; Lüthi U; Arambasic M; Hoppe S; Albers CE; Baerlocher GM; Ochsenbein AF
Cell Rep; 2021 Jan; 34(4):108663. PubMed ID: 33503440
[TBL] [Abstract][Full Text] [Related]
86. C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.
Khan KA; McMurray JL; Mohammed F; Bicknell R
FEBS J; 2019 Sep; 286(17):3299-3332. PubMed ID: 31287944
[TBL] [Abstract][Full Text] [Related]
87. A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma.
Liu J; Yin J; Wang Y; Cai L; Geng R; Du M; Zhong Z; Ni S; Huang X; Yu H; Bai J
Biol Proced Online; 2022 Jul; 24(1):9. PubMed ID: 35836132
[TBL] [Abstract][Full Text] [Related]
88. Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.
Gambaro K; Quinn MC; Cáceres-Gorriti KY; Shapiro RS; Provencher D; Rahimi K; Mes-Masson AM; Tonin PN
BMC Cancer; 2015 Mar; 15():135. PubMed ID: 25886299
[TBL] [Abstract][Full Text] [Related]
89. Characterization of Insulin-Like Growth Factor Binding Protein 7 (Igfbp7) and Its Potential Involvement in Shell Formation and Metamorphosis of Pacific Abalone,
Sharker MR; Hossen S; Nou IS; Kho KH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906674
[TBL] [Abstract][Full Text] [Related]
90. IGFBP7 enhances trophoblast invasion via IGF-1R/c-Jun signaling in unexplained recurrent spontaneous abortion.
Wu PL; Zhu JW; Zeng C; Li X; Xue Q; Yang HX
Reproduction; 2022 Nov; 164(5):231-241. PubMed ID: 35900339
[TBL] [Abstract][Full Text] [Related]
91. IGFBP7: an oncosuppressor gene in thyroid carcinogenesis.
Vizioli MG; Sensi M; Miranda C; Cleris L; Formelli F; Anania MC; Pierotti MA; Greco A
Oncogene; 2010 Jul; 29(26):3835-44. PubMed ID: 20440262
[TBL] [Abstract][Full Text] [Related]
92. Proteomic screen identifies IGFBP7 as a novel component of endothelial cell-specific Weibel-Palade bodies.
van Breevoort D; van Agtmaal EL; Dragt BS; Gebbinck JK; Dienava-Verdoold I; Kragt A; Bierings R; Horrevoets AJ; Valentijn KM; Eikenboom JC; Fernandez-Borja M; Meijer AB; Voorberg J
J Proteome Res; 2012 May; 11(5):2925-36. PubMed ID: 22468712
[TBL] [Abstract][Full Text] [Related]
93. Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells.
Cao Z; Scandura JM; Inghirami GG; Shido K; Ding BS; Rafii S
Cancer Cell; 2017 Jan; 31(1):110-126. PubMed ID: 27989801
[TBL] [Abstract][Full Text] [Related]
94. Expression of IGFBP7 in acute leukemia is regulated by DNA methylation.
Heesch S; Bartram I; Neumann M; Reins J; Mossner M; Schlee C; Stroux A; Haferlach T; Goekbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Cancer Sci; 2011 Jan; 102(1):253-9. PubMed ID: 21040219
[TBL] [Abstract][Full Text] [Related]
95. Synergistic regulation of microglia differentiation by CD93 and integrin β1 in the rat pneumococcal meningitis model.
Qiao N; Zhang J; Zhang Y; Liu X
Immunol Lett; 2022 Dec; 251-252():63-74. PubMed ID: 36336138
[TBL] [Abstract][Full Text] [Related]
96. CD93 and GIPC expression and localization during central nervous system inflammation.
Liu C; Cui Z; Wang S; Zhang D
Neural Regen Res; 2014 Nov; 9(22):1995-2001. PubMed ID: 25598782
[TBL] [Abstract][Full Text] [Related]
97. Significance of Soluble CD93 in Type 2 Diabetes as a Biomarker for Diabetic Nephropathy: Integrated Results from Human and Rodent Studies.
Lee M; Park HS; Choi MY; Kim HZ; Moon SJ; Ha JY; Choi A; Park YW; Park JS; Shin EC; Ahn CW; Kang S
J Clin Med; 2020 May; 9(5):. PubMed ID: 32397261
[TBL] [Abstract][Full Text] [Related]
98. Structural insight into CD93 recognition by IGFBP7.
Xu Y; Sun Y; Zhu Y; Song G
bioRxiv; 2023 Jun; ():. PubMed ID: 37333140
[TBL] [Abstract][Full Text] [Related]
99. Structural insight into CD93 recognition by IGFBP7.
Xu Y; Sun Y; Zhu Y; Song G
Structure; 2024 Mar; 32(3):282-291.e4. PubMed ID: 38218180
[TBL] [Abstract][Full Text] [Related]
100. Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization.
Li Y; Fu L; Wu B; Guo X; Shi Y; Lv C; Yu Y; Zhang Y; Liang Z; Zhong C; Han S; Xu F; Tian Y
Cancer Cell Int; 2023 Sep; 23(1):189. PubMed ID: 37660019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
